Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Anti-leprosy and anti-TB drug that darkens the skin. | Old antibiotic for leprosy, dermatitis herpetiformis and PCP prophylaxis. |
| Body system | Antibiotics | Antibiotics |
| Drug class | Antileprosy medicines | Antileprosy medicines |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Leprosy (multibacillary), Drug-resistant tuberculosis, Mycobacterium avium complex | Leprosy, Dermatitis herpetiformis, Pneumocystis pneumonia prevention, Some blistering skin diseases |
| How it works | Kills leprosy bacteria and calms leprosy reactions. | Kills leprosy bacteria and calms certain skin inflammation. |
| Starts working | Weeks to months | Weeks |
| Half-life | About 70 days | 20–30 hours |
| Typical adult dose | 50 mg a day with 300 mg once a month in multibacillary leprosy (WHO regimen). | 100 mg once a day for leprosy. |
| Forms | Capsule | Tablet |
| Common side effects | Skin and body fluid discolouration, Dry skin, Abdominal pain, Nausea | Skin rash, Headache, Nausea, Blue tinge to lips (methaemoglobinaemia) |
| Serious side effects | Severe abdominal pain with crystal deposits, QT prolongation, Depression from skin colour change | Haemolytic anaemia, Methaemoglobinaemia, DRESS syndrome (dapsone hypersensitivity), Nerve damage, Agranulocytosis |
| Don't take if | Allergy to clofazimine; Severe abdominal pain or bowel obstruction (caution) | G6PD deficiency (risk of severe haemolysis); Severe anaemia; Allergy to sulfonamides (cross-reaction possible) |
| Alcohol | Usually no problem in moderation. No specific interaction. | Best to limit. Alcohol may add to liver stress. |
| Pregnancy | Usually avoidedCrosses the placenta; discoloured newborn skin occurs; use only if essential. | Use with cautionUsed in pregnancy for leprosy; folic acid supplements advised. |
| Breastfeeding | Usually avoidedPasses into milk; the baby's skin may darken. | Use with cautionPasses into milk; watch for haemolysis in the baby. |
| In use since | — | — |
| Brand names | United States: Lamprene (special access)United Kingdom: Lamprene (special import)India: Lamprene, Clofazimine (programme supply) | United States: Dapsone (generic)United Kingdom: Dapsone (generic)India: Dapsone (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H1 | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | J04BA01 | J04BA02 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker